The House Committee on Energy and Commerce yesterday passed a number of AHA-supported bills that would lower prescription drug costs and strengthen the Affordable Care Act marketplaces to improve access and lower the cost of coverage for consumers.  

Among the prescription drug bills passed yesterday was the AHA-supported H.R. 965, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. The bill would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief.

The committee also passed a series of bills that would reinstate critical consumer protections and strengthen the health insurance marketplaces. Among other things, the bills would roll back the administration's rule expanding short-term, limited-duration insurance plans and provide federal funding for enrollment efforts and for states to establish reinsurance programs or help reduce consumer out-of-pocket costs.

"Ensuring patient access to comprehensive, affordable coverage and achieving fair and sustainable drug pricing are two of the AHA's top priorities," the AHA said in a letter yesterday to committee leaders. "We are encouraged by a number of the proposed pieces of legislation, many of which could help advance these shared objectives." 

See the AHA letter for more information on the AHA-supported bills approved by the committee.
 

Related News Articles

Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…
Headline
The Food and Drug Administration today approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or…
Headline
The Food and Drug Administration today released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and…
Headline
The AHA is engaging in early primary states, including Nevada and South Carolina, with ads about affordability and rural health care to ensure issues…
Headline
The House Ways and Means Health Subcommittee yesterday held a hearing on proposals to lower drug prices and promote new cures.  Witness Ge Bai, an…